We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDOG icon
51
Datadog
DDOG
$87.9B
$208M 0.32%
1,681,797
+1,017,830
+153% +$128M
PINS icon
52
Pinterest
PINS
$12.4B
$205M 0.31%
5,914,827
+336,725
+6% +$12.2M
WELL icon
53
Welltower
WELL
$178B
$203M 0.31%
2,169,345
+1,896,321
+695% +$172M
NSC icon
54
Norfolk Southern
NSC
$78.8B
$199M 0.3%
781,140
+451,057
+137% +$112M
SPY icon
55
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$196M 0.3%
374,662
-32,580
-8% -$16.2M
REGN icon
56
Regeneron Pharmaceuticals
REGN
$68.8B
$193M 0.29%
200,387
+105,861
+112% +$101M
DG icon
57
Dollar General
DG
$25.9B
$193M 0.29%
1,235,239
+546,800
+79% +$77.7M
HES
58
DELISTED
Hess
HES
$188M 0.29%
1,232,255
+272,952
+28% +$39.6M
RACE icon
59
Ferrari
RACE
$63.3B
$186M 0.28%
425,699
+80,690
+23% +$31.3M
RJF icon
60
Raymond James Financial
RJF
$32.5B
$185M 0.28%
1,437,978
-455,696
-24% -$53.1M
MRVL icon
61
Marvell Technology
MRVL
$174B
$183M 0.28%
2,578,911
+1,583,599
+159% +$108M
LQD icon
62
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$181M 0.28%
1,665,612
+881,429
+112% +$95.8M
INTC icon
63
Intel
INTC
$466B
$181M 0.28%
4,090,924
-4,378,599
-52% -$195M
CRL icon
64
Charles River Laboratories
CRL
$10.9B
$180M 0.27%
+662,849
New +$158M
CYTK icon
65
Cytokinetics
CYTK
$11B
$179M 0.27%
2,556,803
+1,930,716
+308% +$149M
WHR icon
66
Whirlpool
WHR
$2.42B
$177M 0.27%
1,479,469
+571,263
+63% +$63.7M
MMM icon
67
3M
MMM
$89B
$169M 0.26%
1,906,437
+456,381
+31% +$37.8M
ULTA icon
68
Ulta Beauty
ULTA
$20.4B
$168M 0.26%
321,229
+164,220
+105% +$84.8M
AAPL icon
69
PUT
Apple
AAPL
$4.89T
$166M 0.25%
884,900
+185,800
+27% +$33.8M
BDX icon
70
Becton Dickinson
BDX
$43.1B
$166M 0.25%
669,572
+658,479
+5,936% +$158M
SYK icon
71
Stryker
SYK
$127B
$164M 0.25%
+457,574
New +$154M
LIN icon
72
Linde
LIN
$237B
$164M 0.25%
352,191
+320,857
+1,024% +$139M
FTV icon
73
Fortive
FTV
$19B
$162M 0.25%
2,499,540
+635,803
+34% +$38.6M
MS icon
74
PUT
Morgan Stanley
MS
$337B
$161M 0.25%
1,622,800
+1,607,000
+10,171% +$142M
COO icon
75
Cooper Companies
COO
$13.7B
$161M 0.24%
1,583,895
+388,727
+33% +$37.6M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.